Apomorphine

Trade Name: 
Movapo
Manufacturer/Distributor: 
Britannia Pharmaceuticals Ltd.
Paladin Labs (distributor)
Classification: 
Nonergot-derivative dopamine receptor agonist
ATC Class: 
N04BC07 - apomorphine
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2016/11/22
Date Marketed in Canada (yyyy/mm/dd): 
2018/04/xx
Presentation: 
Syringe for injection: 10 mg/mL. DIN: 02459132 (10 mg/1 mL)
Syringe for injection: 10 mg/mL. DIN: 02459140 (20 mg/2 mL)
Comments: 
For acute intermittent treatment of hypomobility, "off" epidsodes in patients with advanced Parkinson's disease. Given as a subcutaneous injection.